Medical Care

Global Cystic Fibrosis Therapeutics Market Research Report 2024

The Cystic Fibrosis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan
Segment by Type
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CFTR
1.2.3 Mucolytics
1.2.4 PERT
1.2.5 Anti-infectives
1.2.6 Bronchodilators
1.3 Market by Application
1.3.1 Global Cystic Fibrosis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis Therapeutics Market Perspective (2019-2030)
2.2 Cystic Fibrosis Therapeutics Growth Trends by Region
2.2.1 Global Cystic Fibrosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cystic Fibrosis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Cystic Fibrosis Therapeutics Market Dynamics
2.3.1 Cystic Fibrosis Therapeutics Industry Trends
2.3.2 Cystic Fibrosis Therapeutics Market Drivers
2.3.3 Cystic Fibrosis Therapeutics Market Challenges
2.3.4 Cystic Fibrosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue
3.1.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cystic Fibrosis Therapeutics Revenue
3.4 Global Cystic Fibrosis Therapeutics Market Concentration Ratio
3.4.1 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Therapeutics Revenue in 2023
3.5 Cystic Fibrosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Cystic Fibrosis Therapeutics Product Solution and Service
3.7 Date of Enter into Cystic Fibrosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystic Fibrosis Therapeutics Breakdown Data by Type
4.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Cystic Fibrosis Therapeutics Breakdown Data by Application
5.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cystic Fibrosis Therapeutics Market Size (2019-2030)
6.2 North America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)
6.4 North America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cystic Fibrosis Therapeutics Market Size (2019-2030)
7.2 Europe Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)
7.4 Europe Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cystic Fibrosis Therapeutics Market Size (2019-2030)
9.2 Latin America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Detail
11.1.2 Vertex Pharmaceuticals Business Overview
11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.1.5 Vertex Pharmaceuticals Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Cystic Fibrosis Therapeutics Introduction
11.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Detail
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Introduction
11.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.4.5 Gilead Sciences Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Cystic Fibrosis Therapeutics Introduction
11.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Cystic Fibrosis Therapeutics Introduction
11.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.7.5 Bayer Recent Development
11.8 Celtaxsys
11.8.1 Celtaxsys Company Detail
11.8.2 Celtaxsys Business Overview
11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Introduction
11.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.8.5 Celtaxsys Recent Development
11.9 Pharmaxis
11.9.1 Pharmaxis Company Detail
11.9.2 Pharmaxis Business Overview
11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Introduction
11.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.9.5 Pharmaxis Recent Development
11.10 ProQR Therapeutics
11.10.1 ProQR Therapeutics Company Detail
11.10.2 ProQR Therapeutics Business Overview
11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Introduction
11.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.10.5 ProQR Therapeutics Recent Development
11.11 PTC Therapeutics
11.11.1 PTC Therapeutics Company Detail
11.11.2 PTC Therapeutics Business Overview
11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Introduction
11.11.4 PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.11.5 PTC Therapeutics Recent Development
11.12 Alcresta Therapeutics
11.12.1 Alcresta Therapeutics Company Detail
11.12.2 Alcresta Therapeutics Business Overview
11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Introduction
11.12.4 Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.12.5 Alcresta Therapeutics Recent Development
11.13 Insmed Incorporated
11.13.1 Insmed Incorporated Company Detail
11.13.2 Insmed Incorporated Business Overview
11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Introduction
11.13.4 Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.13.5 Insmed Incorporated Recent Development
11.14 Savara
11.14.1 Savara Company Detail
11.14.2 Savara Business Overview
11.14.3 Savara Cystic Fibrosis Therapeutics Introduction
11.14.4 Savara Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.14.5 Savara Recent Development
11.15 Cyclacel Pharmaceuticals
11.15.1 Cyclacel Pharmaceuticals Company Detail
11.15.2 Cyclacel Pharmaceuticals Business Overview
11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Introduction
11.15.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.15.5 Cyclacel Pharmaceuticals Recent Development
11.16 Vectura
11.16.1 Vectura Company Detail
11.16.2 Vectura Business Overview
11.16.3 Vectura Cystic Fibrosis Therapeutics Introduction
11.16.4 Vectura Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.16.5 Vectura Recent Development
11.17 Allergan
11.17.1 Allergan Company Detail
11.17.2 Allergan Business Overview
11.17.3 Allergan Cystic Fibrosis Therapeutics Introduction
11.17.4 Allergan Revenue in Cystic Fibrosis Therapeutics Business (2019-2024)
11.17.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CFTR
Table 3. Key Players of Mucolytics
Table 4. Key Players of PERT
Table 5. Key Players of Anti-infectives
Table 6. Key Players of Bronchodilators
Table 7. Global Cystic Fibrosis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cystic Fibrosis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Cystic Fibrosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Cystic Fibrosis Therapeutics Market Share by Region (2019-2024)
Table 11. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Cystic Fibrosis Therapeutics Market Share by Region (2025-2030)
Table 13. Cystic Fibrosis Therapeutics Market Trends
Table 14. Cystic Fibrosis Therapeutics Market Drivers
Table 15. Cystic Fibrosis Therapeutics Market Challenges
Table 16. Cystic Fibrosis Therapeutics Market Restraints
Table 17. Global Cystic Fibrosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Cystic Fibrosis Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2023)
Table 20. Ranking of Global Top Cystic Fibrosis Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Cystic Fibrosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cystic Fibrosis Therapeutics Product Solution and Service
Table 24. Date of Enter into Cystic Fibrosis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cystic Fibrosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Cystic Fibrosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Cystic Fibrosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Vertex Pharmaceuticals Company Detail
Table 50. Vertex Pharmaceuticals Business Overview
Table 51. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 52. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 53. Vertex Pharmaceuticals Recent Development
Table 54. F. Hoffmann-La Roche Company Detail
Table 55. F. Hoffmann-La Roche Business Overview
Table 56. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product
Table 57. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 58. F. Hoffmann-La Roche Recent Development
Table 59. AbbVie Company Detail
Table 60. AbbVie Business Overview
Table 61. AbbVie Cystic Fibrosis Therapeutics Product
Table 62. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 63. AbbVie Recent Development
Table 64. Gilead Sciences Company Detail
Table 65. Gilead Sciences Business Overview
Table 66. Gilead Sciences Cystic Fibrosis Therapeutics Product
Table 67. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Gilead Sciences Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Cystic Fibrosis Therapeutics Product
Table 72. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. AstraZeneca Company Detail
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Cystic Fibrosis Therapeutics Product
Table 77. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 78. AstraZeneca Recent Development
Table 79. Bayer Company Detail
Table 80. Bayer Business Overview
Table 81. Bayer Cystic Fibrosis Therapeutics Product
Table 82. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Bayer Recent Development
Table 84. Celtaxsys Company Detail
Table 85. Celtaxsys Business Overview
Table 86. Celtaxsys Cystic Fibrosis Therapeutics Product
Table 87. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 88. Celtaxsys Recent Development
Table 89. Pharmaxis Company Detail
Table 90. Pharmaxis Business Overview
Table 91. Pharmaxis Cystic Fibrosis Therapeutics Product
Table 92. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 93. Pharmaxis Recent Development
Table 94. ProQR Therapeutics Company Detail
Table 95. ProQR Therapeutics Business Overview
Table 96. ProQR Therapeutics Cystic Fibrosis Therapeutics Product
Table 97. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 98. ProQR Therapeutics Recent Development
Table 99. PTC Therapeutics Company Detail
Table 100. PTC Therapeutics Business Overview
Table 101. PTC Therapeutics Cystic Fibrosis Therapeutics Product
Table 102. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 103. PTC Therapeutics Recent Development
Table 104. Alcresta Therapeutics Company Detail
Table 105. Alcresta Therapeutics Business Overview
Table 106. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product
Table 107. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 108. Alcresta Therapeutics Recent Development
Table 109. Insmed Incorporated Company Detail
Table 110. Insmed Incorporated Business Overview
Table 111. Insmed Incorporated Cystic Fibrosis Therapeutics Product
Table 112. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 113. Insmed Incorporated Recent Development
Table 114. Savara Company Detail
Table 115. Savara Business Overview
Table 116. Savara Cystic Fibrosis Therapeutics Product
Table 117. Savara Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 118. Savara Recent Development
Table 119. Cyclacel Pharmaceuticals Company Detail
Table 120. Cyclacel Pharmaceuticals Business Overview
Table 121. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 122. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 123. Cyclacel Pharmaceuticals Recent Development
Table 124. Vectura Company Detail
Table 125. Vectura Business Overview
Table 126. Vectura Cystic Fibrosis Therapeutics Product
Table 127. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 128. Vectura Recent Development
Table 129. Allergan Company Detail
Table 130. Allergan Business Overview
Table 131. Allergan Cystic Fibrosis Therapeutics Product
Table 132. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2019-2024) & (US$ Million)
Table 133. Allergan Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cystic Fibrosis Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. CFTR Features
Figure 4. Mucolytics Features
Figure 5. PERT Features
Figure 6. Anti-infectives Features
Figure 7. Bronchodilators Features
Figure 8. Global Cystic Fibrosis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Cystic Fibrosis Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Cystic Fibrosis Therapeutics Report Years Considered
Figure 13. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cystic Fibrosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cystic Fibrosis Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Global Cystic Fibrosis Therapeutics Market Share by Players in 2023
Figure 17. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2023
Figure 19. North America Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)
Figure 21. United States Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)
Figure 25. Germany Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2019-2030)
Figure 33. China Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)
Figure 41. Mexico Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Country (2019-2030)
Figure 45. Turkey Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cystic Fibrosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 49. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 50. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 53. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 54. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 55. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 56. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 57. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 58. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 59. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 60. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 61. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 62. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 63. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies